Development of an ex vivo method for evaluation of precorneal residence of topical ophthalmic formulations.
This paper describes the development of an ex vivo perfusion method for the evaluation of topical ophthalmic formulations. The perfusion system developed consisted of a perfusion chamber, two precision pumps to control the in/out flow rates to simulate the tear flow rate, and a fluorescence microscope imager. Freshly excised rat cornea was used as a biomembrane. Fluorescein (FITC) was used as a marker. Residence time was determined by measuring fluorescence intensity over time after application of the formulation to the cornea. In addition, viscoelastic properties of the formulations were measured and correlated to the retention times. The perfusion method easily differentiated formulations based on the retention time on the cornea: For example, a 0.3% hydroxypropyl methylcellulose formulation had a short retention time of <10 min. Addition of 0.25% carboxymethylcellulose increased the retention time from less than 10 min to over 16 min, and addition of 0.1% Carbopol further increased retention time to over 40 min. For alginate formulations, the retention time was significantly longer in the presence of 0.06% calcium chloride than that of 0.006% calcium chloride. The longer residence time at a higher Ca++ concentration can be attributed to the greater elastic modulus associated with the gel. Interestingly, however, a hyaluronate formulation displayed a very long retention time but has low viscoelastic moduli. This suggests that the mucoadhesive properties may not always be discernable by the rheological properties. The ex vivo perfusion method may in fact provide more meaningful information with regard to retention times of formulations.
Liu
Quan
Q
Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, Pennsylvania 19140, USA.
Wang
Youmin
Y
D000180:Acrylic Resins; D000287:Administration, Topical; D000464:Alginates; D000818:Animals; D002626:Chemistry, Pharmaceutical; D003315:Cornea / Q000378:metabolism*; D004548:Elasticity; D005079:Excipients; D065347:Hypromellose Derivatives; D066298:In Vitro Techniques; D008297:Male; D008747:Methylcellulose / Q000031:analogs & derivatives; D015233:Models, Statistical; D009077:Mucins / Q000737:chemistry; D009883:Ophthalmic Solutions / Q000493:pharmacokinetics*; D019999:Pharmaceutical Solutions; D011145:Polyvinyls; D051381:Rats; D012212:Rheology; D013050:Spectrometry, Fluorescence; D014783:Viscosity
D000180:Acrylic Resins; D000464:Alginates; D005079:Excipients; D009077:Mucins; D009883:Ophthalmic Solutions; D019999:Pharmaceutical Solutions; D011145:Polyvinyls; C006912:carboxypolymethylene; D065347:Hypromellose Derivatives; D008747:Methylcellulose